Pham Quang X's Form 4 filing
Cadrenal Therapeutics, Inc. (CVKD) · filed Jun 18, 2026
- Accession no.
- 0001213900-26-070248
- Filed
- Jun 18, 2026
- Trade date
- Jun 16-17, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $13.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pham Quang XCIK 0001405290 | Director, Officer (Chairman, CEO and Interim CFO), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 16, 2026 | Common Stock | SSaleDisposed | −3,613 | $3.18 | −$11,489.34 | 129,102 | Direct | |
| Jun 17, 2026 | Common Stock | SSaleDisposed | −513 | $3.16 | −$1,621.08 | 128,589 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.